STAAR Surgical | STAA - Equity Capital And Reserves


STAAR Surgical reported $352.37M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Bausch Health Companies USD -2.06B 1.5B Mar/2026
Boston Scientific USD 25.86B 1.63B Mar/2026
Cerus USD 64.22M 2.76M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
J&J USD 81.19B 358M Mar/2026
Merit Medical Systems USD 1.63B 42.42M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
OraSure Technologies USD 313.32M 27.5M Mar/2026
Orthofix International USD 435.19M 14.85M Mar/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 352.37M 8.18M Mar/2026
Utah Medical Products USD 119.27M 1.02M Dec/2025